About AVT
Browse Articles
Customer Services


Antiretroviral drugs to prevent breastfeeding HIV transmission

Lynne M Mofenson

Corresponding author name: Lynne M Mofenson
Corresponding author e-mail: LM65D@nih.gov

Citation: Antiviral Therapy 2010; 15:537-553
doi: 10.3851/IMP1574

Date accepted: 05 April 2010
Date published online: 25 June 2010


Observational studies and randomized clinical trials demonstrating that antiretroviral prophylaxis of the breastfeeding infant or triple-drug antiretroviral prophylaxis of the lactating mother can significantly affect the risk of postnatal transmission of HIV via breast milk have recently become available. In resource-limited countries, breastfeeding is a cornerstone of infant survival. While shortening the duration of breastfeeding by HIV-infected women reduces postnatal HIV transmission, increasing data suggest this may also decrease overall infant survival. Thus, there is a crucial need for interventions to allow safer and more prolonged breastfeeding. This paper will critically review the results of studies of postnatal antiretroviral prophylaxis to prevent breast milk HIV transmission.


Copyright © 2019 Nucleus Holdings Ltd. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.